Chompootaweep S, Nunthapisud P, Trivijitsilp P, Sentrakul P, Dusitsin N
Department of Pharmacology, Faculty of Medicine, and the Institute of Health Research, Chulalongkorn University, and the BNH Hospital.
Clin Pharmacol Ther. 1998 Aug;64(2):204-10. doi: 10.1016/S0009-9236(98)90154-0.
To determine whether the combined contraceptive pill used intravaginally was as effective as the standard conjugated estrogen cream for the treatment of urogenital symptoms in postmenopausal Thai women.
In a randomized clinical trial, 40 postmenopausal women with urogenital symptoms were randomly allocated to two treatment groups for 8 weeks. The first group (n = 20) received a combined contraceptive pill by the vaginal route, one tablet per week at bedtime for 8 weeks. Each tablet contained 250 microg levonorgestrel plus 30 microg ethinyl estradiol. The second group (n = 20) was given 1 gm of an intravaginal conjugated estrogen cream at bedtime, three times in the first week, twice in the second week, and then once a week for the next 6 weeks (1 gram of conjugated estrogen cream contained 0.625 mg conjugated equine estrogens). Subjects were questioned about their urogenital symptoms, and vaginal cytologic smears, vaginal bacterial cultures, and urine cultures were performed before treatment and after 2, 4, and 8 weeks of therapy.
The vaginal pH and the proportion of the fecal type bacteria decreased in both groups, with no statistically significant difference between the groups. The karyopyknotic index and the maturation index were improved during treatment in both groups. An increase in the proportion of lactobacilli were recorded in both groups after therapy, with no significant difference between the two groups. No significant changes were observed in urinary bacteria. The therapy (combined contraceptive pill and estrogen cream) had a marked effect on urogenital symptoms (vaginal dryness, dyspareunia, urinary frequency, and urinary urgency), with impressive improvement comparably in both groups.
A combined contraceptive tablet administered vaginally once a week can alleviate urogenital symptoms in Thai postmenopausal women as effectively as the vaginal estrogen cream. However, the pills are much less expensive and are easily obtained in developing countries.
确定经阴道使用复方避孕药丸是否与标准结合雌激素乳膏在治疗泰国绝经后女性泌尿生殖系统症状方面效果相当。
在一项随机临床试验中,40名有泌尿生殖系统症状的绝经后女性被随机分为两个治疗组,为期8周。第一组(n = 20)经阴道途径使用复方避孕药丸,每周睡前服用1片,共8周。每片含250微克左炔诺孕酮加30微克炔雌醇。第二组(n = 20)在睡前给予1克阴道用结合雌激素乳膏,第1周3次,第2周2次,随后6周每周1次(1克结合雌激素乳膏含0.625毫克结合马雌激素)。询问受试者泌尿生殖系统症状,并在治疗前及治疗2、4和8周后进行阴道细胞学涂片、阴道细菌培养和尿液培养。
两组阴道pH值和粪便型细菌比例均下降,组间差异无统计学意义。两组治疗期间核固缩指数和成熟指数均得到改善。治疗后两组乳酸杆菌比例均增加,两组间无显著差异。尿液细菌无显著变化。治疗(复方避孕药丸和雌激素乳膏)对泌尿生殖系统症状(阴道干燥、性交困难、尿频和尿急)有显著效果,两组改善程度相当。
每周经阴道给药1次的复方避孕药丸在缓解泰国绝经后女性泌尿生殖系统症状方面与阴道雌激素乳膏效果相当。然而,避孕药丸成本低得多,在发展中国家容易获得。